Google’s NotebookLM Update Adds Deep Research, Expanded File Formats

Google’s latest release raises the platform’s research capabilities with structured analysis, clear sourcing, and support for ...
Clinical Trials Arena on MSN

Gilead’s HIV single-pill combo meets primary endpoints in pivotal trial

Gilead has become a significant name in the HIV landscape after its twice-yearly PrEP treatment Yeztugo touted 99.9% efficacy ...
Morningstar

Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystrophy

First returning adult patient from Phase 1b study recently dosed; additional returning patients being scheduled 11-month open-label study will evaluate functional outcomes, safety, muscle composition ...
FOX8 Cleveland

‘Should not have happened’: Ohio police file charges against wrong Danielle Taylor

COLUMBUS, Ohio (WCMH) — A woman said she spent 12 hours in jail and was wrongfully charged for a crime she didn’t commit. Turns out, Reynoldsburg Police filed charges against the wrong Danielle Taylor ...
IEEE

GIDDM: Generating Labels with Diffusion Model to Promote Cross-domain Open-set Image Recognition

Abstract: Due to the lack of prior knowledge about unknown classes during training, existing methods for cross-domain open-set image recognition typically rely on threshold-based solutions. However, ...
ophthalmologytimes

AAO 2025: Arshad M. Khanani, MD, highlights 3-year results from the GATHER2 open-label extension trial

The 18-month extension of the GATHER2 trial indicated continued benefit for patients receiving avacincaptad pegol, with efficacy gains increasing over time. Arshad M. Khanani, MD, MA, FASRS, of Sierra ...
oncnursingnews

Open-Label Ponsegromab Appears Effective in Cancer-Associated Cachexia

Ponsegromab increased body weight in patients with cancer-associated cachexia, yielding greater improvement in those who received ponsegromab previously. Ponsegromab treatment over 64 weeks resulted ...
The Lancet

IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study

aDepartment of Hematology, Centre for Leading Medicine and Advanced Technologies of Institute of Health and Medicine, The First Affiliated Hospital of University of Science and Technology of China, ...
BMJ

Dose-averaged LET escalation with multi-ion therapy for head and neck cancers: a phase I study protocol for a prospective, open-label, single-arm, single-centre trial (MULTI ...

Introduction The standard treatment for unresectable head and neck cancer typically involves radiotherapy (RT) alone or chemoradiotherapy (chemo-RT). Non-squamous cell carcinomas exhibit relatively ...